Article citationsMore>>
Schauer, P.R., Bhatt, D.L., Kirwan, J.P., Wolski, K., Brethauer, S.A., Navaneethan, S.D., Aminian, A., Pothier, C.E., Kim, E.S., Nissen, S.E. and Kashyap, S.R., STAMPEDE Investigators (2014) Bariatric Surgery versus Intensive Medical Therapy for Diabetes—3-Year Outcomes. The New England Journal of Medicine, 370, 2002-2013.
http://dx.doi.org/10.1056/NEJMoa1401329
has been cited by the following article:
-
TITLE:
Progressive β Cell Failure in Type 2 Diabetes Mellitus: Microvascular Pancreatic Isletopathy?
AUTHORS:
Udaya M. Kabadi, Mary U. Kabadi, Sommany Weber, Aaron Bubolz, Edward Finnerty
KEYWORDS:
Type 2 Diabetes, Beta Cell Failure, Pancreatic Isletopathy
JOURNAL NAME:
Journal of Diabetes Mellitus,
Vol.5 No.1,
January
13,
2015
ABSTRACT: Background: UKPDS suggested relentless deterioration of β cell function as a part of natural course of type 2 diabetes mellitus. However, the course was apparently not universal since many patients maintained glycemic goal (HbA1c β cell failure occurred around the same time as the time of onset of microvascular complications. Finally, the exact mechanism of progressive β cell failure remains to be defined. It is plausible that β cell failure may be due to fibrosis of pancreatic islets secondary to microangiopathy since no organ or tissue is exempt from this complication. Objective: To assess epidemiologic correlation between presence of b cell failure and microvascular complications by determining the prevalence of β cell failure in subjects with type 2 diabetes with increasing number of known microvascular complications. Methods: 650 Subjects with ages 40-75 years and duration of DM 4-23 years were divided into 4 groups according to number of microvascular complications, e.g. retinopathy, nephropathy, and neuropathy. β cell failure (β -ve ) is defined as HbA1c > 7.0% with any therapy or HbA1c β cell function is deemed “preserved” (β + ve) with HbA1c b cell failure progressively rose with increasing number of microvascular complications from 0 to 2 with no further significant rise with 3 complications whereas subjects with preserved β cell function declined with increasing number of microvascular complications (p β cell failure (p β cell failure/β cell preserved with increasing number of microvascular complications as well as the greater duration of Diabetes. However, a significantly (p β cell failure persisted for rising number of microvascular complications even after eliminating the influence of age and duration of diabetes. Conclusion: β cell failure may be a manifestation of microvascular pancreatic isletopathy similar to other microvascular complications.
Related Articles:
-
Theophilus Akinfenwa Fashanu, Vincent Olusegun Sowemimo Olunloyo
-
Rakesh K. Mishra, Ashutosh K. Tewari
-
Ryan N. Shely, Gregory S. King, Marintha R. Short
-
Ana Maria Gomes dos Santos, Maria José Medeiros da Fonseca, Fernanda Fayane C. Belarmino, Adriana Vitória dos Santos, Fábia Barbosa de Andrade
-
Fadila Moussaoui, Tajelmolk Alaoui, Saadia Aoudry